Updated: February 9, 2024
1
Filter
Overview
- As per Volza’s Peru Import data, Dolutegravir import shipments in Peru stood at 209, imported by 15 Peru Importers from 22 Suppliers.
- Peru imports most of its Dolutegravir from India, United Kingdom and United States .
- The top 3 importers of Dolutegravir are India with 680 shipments followed by South Africa with 631 and Tanzania at the 3rd spot with 606 shipments.
- Top 3 Product Categories of Dolutegravir Imports in Peru are
These facts are updated till 9 Feb 2024, and are based on Volza's Peru Import dataPeru Import data of Dolutegravir sourced from 70 countries export import shipments with names of buyers, suppliers, top Decision maker's contact information like Direct, phone, email and LinkedIn profiles.
Dolutegravir import data of Peru - 209 import shipments
All Filters
Applied Filters
PeruX
Top HSN Code
By Shipments
By Name
Top Exporting Countries
By Shipments
By Name
India
(129)United Kingdom
(59)United States
(9)Mexico
(6)Chile
(3)Poland
(2)Argentina
(1)View More (7)
Top Importing Countries
By Shipments
By Name
Zambia
(239)Chile
(237)Peru
(209)United Arab Emirates
(170)Malawi
(167)Vietnam
(135)Ghana
(121)Argentina
(113)Brazil
(90)Congo
(87)Netherlands
(86)France
(80)Botswana
(74)Belgium
(69)Angola
(68)Singapore
(68)Slovenia
(66)Mali
(64)Turkey
(63)United States
(63)Canada
(62)Myanmar
(60)Sudan
(59)Mexico
(57)Thailand
(57)Philippines
(56)Belarus
(50)Russia
(49)Ethiopia
(47)Ukraine
(47)Indonesia
(44)Cuba
(43)Malaysia
(42)Cambodia
(41)Haiti
(41)Switzerland
(41)Namibia
(39)Ivory Coast
(38)Cameroon
(37)Burundi
(36)Oman
(35)Kyrgyzstan
(34)South Korea
(34)Madagascar
(33)Kazakhstan
(32)Papua New Guinea
(32)Paraguay
(32)Ecuador
(31)El Salvador
(31)Panama
(31)Vanuatu
(31)Uzbekistan
(29)Burkina Faso
(28)Dominican Republic
(28)Lesotho
(28)Greece
(26)Benin
(25)Seychelles
(25)Togo
(24)Hong Kong
(23)Pakistan
(23)Gambia
(22)Venezuela
(22)Egypt
(21)Gabon
(21)Jamaica
(21)Japan
(21)Swaziland
(20)Equatorial Guinea
(19)Bangladesh
(18)Guatemala
(18)Rwanda
(18)Armenia
(17)Bolivia
(17)Lithuania
(17)Denmark
(16)Georgia
(16)United Kingdom
(16)Nepal
(15)Tajikistan
(15)Djibouti
(14)Guyana
(14)Morocco
(14)Barbados
(13)Cape Verde Islands
(13)Honduras
(13)Saudi Arabia
(13)Afghanistan
(11)Bhutan
(11)Laos
(11)Somalia
(11)Liberia
(10)Malta
(10)Poland
(10)Azerbaijan
(9)Bahamas
(9)Central African Republic
(9)Chad
(9)China
(9)Costa Rica
(9)Guinea
(9)Lebanon
(9)Moldova
(9)Uruguay
(9)Guinea Bissau
(8)Mauritius
(8)Nicaragua
(8)Sri Lanka
(8)Fiji
(7)Saint Lucia
(7)Algeria
(6)Germany
(6)Senegal
(6)Sierra Leone
(6)Tunisia
(6)Albania
(5)Eritrea
(5)Grenada
(5)Suriname
(5)Turkmenistan
(5)Turks and Caicos Islands
(5)Belize
(4)Bermuda
(4)British Virgin Islands
(4)Colombia
(4)East Timor
(4)Iraq
(4)Jordan
(4)Maldives
(4)Mauritania
(4)Sao Tome And Principe
(4)Spain
(4)Yemen
(4)Australia
(3)Comoros
(3)Iran
(3)Niger
(3)Syria
(3)Anguilla
(2)Czech Republic
(2)Dominica
(2)Finland
(2)Micronesia
(2)Mongolia
(2)Romania
(2)Saint Kitts And Nevis
(2)Austria
(1)Bahrain
(1)Latvia
(1)Libya
(1)Serbia And Montenegro
(1)Taiwan
(1)View More (160)
Top Related HSN Code
By Shipments
By Name
Top Related Products
By Shipments
By Name
Export Data by Country
By Shipments
By Name
South Africa
(62)Canada
(41)South Korea
(30)Slovenia
(28)United Arab Emirates
(26)Germany
(22)Spain
(22)Uganda
(17)France
(12)Argentina
(10)Thailand
(9)Indonesia
(8)Italy
(8)Japan
(7)Ecuador
(6)Mexico
(6)Poland
(6)Singapore
(5)Brazil
(4)Chile
(4)Turkey
(4)Australia
(3)Belgium
(3)Kenya
(2)Malaysia
(2)Malta
(2)Mauritius
(2)Netherlands
(2)Zambia
(2)North Korea
(1)Greece
(1)Hong Kong
(1)Israel
(1)Morocco
(1)Peru
(1)Philippines
(1)Zimbabwe
(1)View More (41)
Top Buyer Countries
By Shipments
By Name
Chile
(45)Kenya
(38)Uganda
(36)United States
(36)Vietnam
(31)Mozambique
(29)Tanzania
(26)Zimbabwe
(26)Nigeria
(24)Congo
(22)Ukraine
(21)Turkey
(20)United Arab Emirates
(19)Zambia
(17)Angola
(17)Ivory Coast
(17)Netherlands
(16)Thailand
(16)Russia
(16)Namibia
(16)Peru
(15)Brazil
(15)Singapore
(15)Myanmar
(15)Cambodia
(15)Haiti
(15)Kyrgyzstan
(15)Uzbekistan
(15)Argentina
(14)Indonesia
(14)Malaysia
(14)Botswana
(13)Cameroon
(13)Oman
(13)Japan
(13)Ghana
(12)France
(12)Egypt
(12)Belgium
(11)Canada
(11)Burundi
(11)Guatemala
(11)Sudan
(10)Kazakhstan
(10)Ecuador
(10)El Salvador
(10)Burkina Faso
(10)Benin
(10)Pakistan
(10)Swaziland
(10)Mali
(9)Belarus
(9)Ethiopia
(9)Dominican Republic
(9)Togo
(9)Venezuela
(9)Equatorial Guinea
(9)Slovenia
(8)Philippines
(8)Switzerland
(8)Panama
(8)Armenia
(8)Nepal
(8)Malawi
(7)Papua New Guinea
(7)Rwanda
(7)Denmark
(7)United Kingdom
(7)Djibouti
(7)Barbados
(7)China
(7)Guinea
(7)Sri Lanka
(7)Fiji
(7)Mexico
(6)Lesotho
(6)Gabon
(6)Georgia
(6)Tajikistan
(6)Saudi Arabia
(6)Bhutan
(6)Laos
(6)Moldova
(6)Guinea Bissau
(6)Cuba
(5)South Korea
(5)Madagascar
(5)Jamaica
(5)Bangladesh
(5)Bolivia
(5)Lithuania
(5)Morocco
(5)Honduras
(5)Poland
(5)Bahamas
(5)Costa Rica
(5)Mauritius
(5)Saint Lucia
(5)Germany
(5)Senegal
(5)Seychelles
(4)Somalia
(4)Liberia
(4)Malta
(4)Azerbaijan
(4)Central African Republic
(4)Chad
(4)Lebanon
(4)Eritrea
(4)Bermuda
(4)Jordan
(4)Mauritania
(4)Paraguay
(3)Greece
(3)Hong Kong
(3)Gambia
(3)Guyana
(3)Cape Verde Islands
(3)Afghanistan
(3)Nicaragua
(3)Sierra Leone
(3)Tunisia
(3)Turks and Caicos Islands
(3)Belize
(3)Iraq
(3)Yemen
(3)Australia
(3)Comoros
(3)Iran
(3)Vanuatu
(2)Uruguay
(2)Algeria
(2)Albania
(2)Grenada
(2)British Virgin Islands
(2)Colombia
(2)East Timor
(2)Sao Tome And Principe
(2)Niger
(2)Czech Republic
(2)Dominica
(2)Mongolia
(2)Suriname
(1)Turkmenistan
(1)Maldives
(1)Spain
(1)Syria
(1)Anguilla
(1)Finland
(1)Micronesia
(1)Romania
(1)Saint Kitts And Nevis
(1)Austria
(1)Bahrain
(1)Latvia
(1)Libya
(1)Serbia And Montenegro
(1)Taiwan
(1)View More (160)
Top Supplier Countries
By Shipments
By Name
United States
(36)United Kingdom
(26)China
(22)South Africa
(16)Canada
(12)Germany
(7)United Arab Emirates
(6)Spain
(5)Uganda
(5)France
(4)Indonesia
(4)Singapore
(4)Thailand
(3)Ecuador
(3)Australia
(3)South Korea
(2)Italy
(2)Japan
(2)Brazil
(2)Chile
(2)Turkey
(2)Belgium
(2)Kenya
(2)Malaysia
(2)Malta
(2)Netherlands
(2)Slovenia
(1)Argentina
(1)Mexico
(1)Poland
(1)Mauritius
(1)Zambia
(1)North Korea
(1)Greece
(1)Hong Kong
(1)Israel
(1)Morocco
(1)Philippines
(1)Zimbabwe
(1)Peru
(0)View More (41)
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
|---|
| 3004902400 | GSK1349572 50MG S/M S/M|ESTE PRODUCTO EN INVESTIGACION ES UN ANTIRETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION|POR EL VIH. ES UN FRASCO QUE CONTIENE 30 TABLETAS // LOTE: 142386775, F DE VCTO: 12/2016|DOLUTEGRAVIR (GSK1349572) X 30 COMPRIMIDOS, 50MG|GSK1349572 50MG DOLUTEGRAVIR (GSK1349572) 30 X COMPRIMIDOS | United Kingdom | Peru | 75 |   | | |
| 3004902400 | GSK1349572 50MG S/M S/M|ESTE PRODUCTO EN INVESTIGACION ES UN ANTIRETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION|POR EL VIH. ES UN FRASCO QUE CONTIENE 30 TABLETAS // LOTE: 142386775, F DE VCTO: 12/2016|DOLUTEGRAVIR (GSK1349572) X 30 COMPRIMIDOS, 50MG|GSK1349572 50MG DOLUTEGRAVIR (GSK1349572) 30 X COMPRIMIDOS | United Kingdom | Peru | 103 | | | |
| 3004902400 | MEDICAMENTO TIVICAY S/M|DOLUTEGRAVIR|MEDICAMENTO DE USO HUMANO VIH/SIDA PARA ANALISIS E INVESTIGACION, PROTOCOLO AI468-048|FRASCO X 30 TABLETAS - S.V.C.|TIVICAY TAB 50MG 1BTLX30 AI 468048 OLMUL, LOTE AAC7588 VCTO 02/2017 | United Kingdom | Peru | 40 | | | |
| 3004201100 | DOLUTEGRAVIR SODICO, GLAXOSMITHKLINE, S/MOD|LOTE: 142386810 // EXPIRA: 30/06/2018 // PRINCIPIO ACTIVO: DOLUTEGRAVIR SODICO|DOLUTEGRAVIR (GSK1349572) // FRASCO CONTENIENDO 30 COMPRIMIDOS|LABELLED BOTTLE CONTAINING DOLUTEGRAVIR 30CT 50MG TABLETS|R.D.N¦ 4970-2016/DIGEMID/DPF 14/06/2016 - 14/06/2017 // PROTOCOLO: ING117175,R.D.N¦ 165-2 | United Kingdom | Peru | 165 | | | |
| 3004902400 | MEDICAMENTO TIVICAY S/M|DOLUTEGRAVIR SODICO EQUIVALENETE A 50MG DE DOLUTEGRAVIR|MEDICAMENTO DE USO HUMANO VIH/SIDA PARA ANALISIS E INVESTIGACION, PROTOCOLO AI438-047|FRASCO X 30 TABLETAS - S.V.C.|TIVICAY COMP.REC.50MG, LOTE TX4J VCTO 10/2017 | United Kingdom | Peru | 30 | | | 60 More Columns Available |
| 3004902400 | DOLUTEGRAVIR,S/M,S/M,|MEDICAMENTOS PARA TRATAMIENTO DE VIH|ES UN ANTI-RETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION POR EL VIH|FRASCO 30 TABLETAS,LOTE: 172401790 EXP.03/2019|GSK1349572 50MG DOLUTEGRAVIR 30 X COMPRIMIDOS, FRASCO QUE CONTENDRA 30 TABLETAS,N¦PARTE: G | United Kingdom | Peru | 100 | | | |
| 3004902400 | DOLUTEGRAVIR,S/M,S/M,|MEDICAMENTOS PARA TRATAMIENTO DE VIH|ES UN ANTI-RETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION POR EL VIH|FRASCO 30 TABLETAS,LOTE: 182407426 MFG:03.05.2017,EXP.31.05.2021|GSK1349572 50MG DOLUTEGRAVIR 30 X COMPRIMIDOS, FRASCO QUE CONTENDRA 30 TABLETAS,N¦PARTE: G | United Kingdom | Peru | 100 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG, GLAXO OPERATIONS UK, S/M|PRINCIPIO ACTIVO: DOLUTEGRAVIR, DTG|LOT NUMBER: 182411869 // EXPIRY DATE: 30-NOV-2020 // PROTOCOLO: GSK 205543|KIT CONTENIENDO UN FRASCO CON 30 COMPRIMIDOS DE DOLUTEGRAVIR 50MG|MUESTRAS SIN VALOR COMERCIAL | United Kingdom | Peru | 40 | | | |
| 3004902400 | GSK1349572 50MG, S/M, S/M|50 MG|PARA USO EN ESTUDIO CLINICO|DOLUTEGRAVIR 30 X COMPRIMIDOS (GSK1349572)|PK LOT: 182411495 MFG: 04/05/2017 EXPIRY 31/05/2021,NO COMMERCIAL VALUE | United Kingdom | Peru | 130 | | | |
| 3004902400 | TENOFOVIR +LAMIVUDINA+DOLUTEGRAVIR , S-M , S-M|LOTE N¦ 3132774 MFG: 04.2021 EXP: 03.2024|DOLUTEGRAVIR-LAMIVUDINA-TENOFOVIR DISOPROXIL FUMARATE 50MG-300MG-300MG|DOLUTEGRAVIR-LAMIVUDINA-TENOFOVIR DF50-300-300MG TABLETAS|73 , 000 FRASCOS X 30 COMPRIMIDOS , FABRICANTE MYLAN LABORATORIES LIMITED 3004902400 HS Code | India | Peru | 73000 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 458 , 000 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 48600 | | | |
| 3004902400 | DOLUTEGRAVIR TABLETAS 50MG , S-M , S-M|LOTE N¦ E220039A MFG:01.2022 EXP:12.2024|DOLUTEGRAVIR 50MG TABLETA RECUBIERTA|DOLUTEGRAVIR 50MG TAB|CAJA DE CART+N , 01 FRASCO DE POLIETILENO DE ALTA DENSIDAD CON 30 TABLETAS , INCOTERMS: DPU | India | Peru | 2016 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143483 , 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 116 , 640 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 3888 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 8124448 FAB: 07.2021 VENCE: 06.2024; 3142301 FAB: 10.2021 VENCE: 09.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 121 , 160 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 37372 | | | |
| 30049099 | TABLETS >> DOLUTEGRAVIR TABLETS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM FINISHED GOODS:INSTGRA TABLETS Dolutegravir Tablets 50mg PACK size 1x30 ; GOODS :INSTGRA 30049099 HS Code | India | Peru | 2648 | | | |
| 30049099 | DOLUTEGRAVIR TAB 50MG 30BT | India | Peru | 1839 | | | |
| 30042099 | DOLUTEGRAVIR 50MG LAMIVUDINE 300MG TENOF | India | Peru | 536640 | | | |
| 30049099 | DOLUTEGRAVIR 50 MG / LAMIVUDINA 300 MG /TENOFOVIR DISOPROXIL FUMARATO 300 MG TABLETS WITHOUT SPECIAL TEXTPS: 1X30S | India | Peru | 240 | | | |
| 30049099 | NET CONTENT ITEM NO 3LAMIVUDINE 104.1570 KGS,TENOFOVIR DISOPROXIL FUMARATE 104.1570KGS& DOLUTEGRAVIR SODIUM 17.3595 KGS | India | Peru | 0.00 | | | |
| 30049099 | SAMPLES OF NO COMMERCIAL VALUE DOLUTEGRAVIR+ LAMIVUDINE+TENOFOVIR 50MG+300 MG+300MG TABLETS 1X30S 2 PAC | India | Peru | 60 | | | |
| 3004201100 | DOLUTEGRAVIR SODICO, GLAXOSMITHKLINE, S/MOD|BOTTLE // LOTE: 152391726 // EXPIRA: 31/03/2019|FRASCO X 30 TABLETAS|GSK1349572 (DOLUTEGRAVIR, DTG), FILM COATED TABLETS 50 MG IN THE BOTTLE, 30 TABLETS PER|R.D.N¦ 4196-2017-DIGEMID/DPF/UFM/MINSA // R.D.N¦ 149-2017-OGITT-OPE/INS,D.S.N¦ 023-2016-S | United Kingdom | Peru | 180 | | | |
| 3004902900 | DOLUTEGRAVIR, VIIV HEALTHCARE, S/MOD|LOTE: 7ZP5316 // EXPIRA: 31/08/2019 // FRASCO CONTENIENDO 30 TABLETAS|MEMORANDUN N¦ 1949-2018-DIGEMID-DG-DFAU-UFAM/MINSA // OFICIO N¦ 1250-2018-OGCTI/MINSA|DOLUTEGRAVIR TABLET 50 MG, 30 TABLETS/BOTTLE|R.D.N¦ 5657-2018/DIGEMID/DPF/AESC/MINSA // SE ADJUNTA CARTA DE DONACION,R.D.N¦ 452-2017-OG | United States | Peru | 5 | | | |
| 3004902400 | DOLUTEGRAVIR,S/M,S/M,|MEDICAMENTOS PARA TRATAMIENTO DE VIH|ES UN ANTI-RETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION POR EL VIH|FRASCO 30 TABLETAS,LOTE: 172404696 EXP.05/2021|GSK1349572 50MG DOLUTEGRAVIR 30 X COMPRIMIDOS, FRASCO CON 30 TABLETAS,N¦PARTE: GSK1349572 | United Kingdom | Peru | 100 | | | |
| 3004902400 | GSK1349572 50MG , S-M , S-M|50 MG|PARA USO EN ESTUDIO CLINICO|DOLUTEGRAVIR 30 X COMPRIMIDOS (GSK1349572) |PK LOT: 182411495 MFG: 04-05-2017 EXPIRY 31-05-2021 , NO COMMERCIAL VALUE | United Kingdom | Peru | 130 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG|PRINCIPIO ACTIVO: DOLUTEGRAVIR|LOT NUMBER: 172402704 / 172403279 // EXPIRY DATE: 31-MAY-21|KIT CONTENIENDO UN FRASCO CON 30 COMPRIMIDOS DE DOLUTEGRAVIR 50MG|MUESTRAS SIN VALOR COMERCIAL | United Kingdom | Peru | 175 | | | |
| 3004391100 | INSTGRA TABLETS|DOLUTEGRAVIR 50 MG TABLETS|S/M|MEDICAMENTO PARA EL TRATAMIENTO DEL VIH USO HUMANO|INSTGRA | India | Peru | 3464 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 8124448 FAB: 07.2021 VENCE: 06.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTTLE = 349 , 920 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 11664 | | | |
| 3004902400 | DOLUTEGRAVIR TABLETAS 50MG , S-M , S-M|LOTE N¦ 8117301 FAB: 01-2021 VENCE: 12-2022|DOLUTEGRAVIR 50MG TABLETA RECUBIERTA|DOLUTEGRAVIR 50MG TAB 30S | India | Peru | 7523 | | | |
| 3004902400 | TENOFOVIR DISOPROXIL FUMARATE 300MG + LA , S-M , S-M|LOTE N¦ 8116917 FAB: 15-01-2021 VENCE: 31-12-2023|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS.| (TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG) TAB 30`S|ANTIRRETROVIRALES PARA TRATAR PACIENTES CON VIH-SIDA | India | Peru | 73000 | | | |
| 3004902400 | TENOFOVIR +LAMIVUDINA+DOLUTEGRAVIR , S-M , S-M|LOTE N¦ 3132774 MFG: 04.2021 EXP: 03.2024|DOLUTEGRAVIR-LAMIVUDINA-TENOFOVIR DISOPROXIL FUMARATE 50MG-300MG-300MG|DOLUTEGRAVIR-LAMIVUDINA-TENOFOVIR DF50-300-300MG TABLETAS|73 , 000 FRASCOS X 30 COMPRIMIDOS , FABRICANTE MYLAN LABORATORIES LIMITED 3004902400 HS Code | India | Peru | 73000 | | | |
| 3004902400 | MEDICAMENTO ANTIVIRAL, S/M, S/M|TABLETAS DE 50/600/300MG|PARA USO Y TRATAMIENTO DE VIH / FRA C/30|PRINCIPIO ACTIVO: ABACAVIR+LAMIVUDINA+DOLUTEGRAVIR|RECETA MEDICA VISADA N¦ 452/2021 DIGEMID | Mexico | Peru | 1 | | | |
| 3004902400 | TENOFOVIR +LAMIVUDINA+DOLUTEGRAVIR, REXP, S/M|LOTE N¦ 3123261 FAB:09.2020 VENCE:08.2023|MEDICAMENTOS PARA PACIENTES CON TRATAMIENTO CR+NICOS Y PARTICULARMENTE|DOLUTEGRAVIR+LAMIVUDINA+TENOFOVIR 50/300/300MG|INFECTADOS POR VIH, FABRICANTE: MYLAN LABORATORIES LIMITED | India | Peru | 4000 | | | |
| 3004902400 | DOLUTEGRAVIR TABLETAS 50MG, S/M, S/M|LOTE N¦ 8117301 FAB: 01-2021 VENCE: 12-2022|DOLUTEGRAVIR 50MG TABLETA RECUBIERTA|DOLUTEGRAVIR 50MG TAB 30S | India | Peru | 7523 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3132179 FAB: 03.2021 VENCE: 02.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTTLE = 233 , 280 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 7776 | | | |
| 2942000000 | WORKING STANDARD TENOFOVIR + DOLUTEGRAVI , S-M , S-M|LOTE N¦ 20146751 FAB: 21.03.22 VENCE: 10.03.23; 22139509 FAB: 30.09.21 VENCE: 20.09.22|PARA USO DE CONTROL DE CALIDAD|TENOFOVIR DF 3GM 3 VAILS + DOLUTEGRAVIR (PEPFAR) 2GM 1 VAILS | India | Peru | 4 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (53 , 452 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122146A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 53452 | | | |
| 3004201100 | TIVICAY , GLAXOSMITHKLINE PHARMACEUTICALS S.A , S-MOD|MFG: 10-05-2021 - EXPIRA: 30-04-2026|R.D.N¦ 2485-2022-DIGEMID-DPF-EEYS-MINSA|DOLUTEGRAVIR SODIUM (TIVICAY) 50 MG TABLETS , 30 TABLETS PER BOTTLE|R.D.N¦ 455-2021-OGITT-INS - R.D.N¦ 487-2021-OGITT-INS - R.D.N¦ 050-2022-OGITT-INS | United Kingdom | Peru | 89 | | | |
| 2942000000 | WORKING STANDARD TENOFOVIR + DOLUTEGRAVI , S-M , S-M|LOTE N¦ 20146751 FAB: 21.03.22 VENCE: 10.03.23; 22139509 FAB: 30.09.21 VENCE: 20.09.22|PARA USO DE CONTROL DE CALIDAD|TENOFOVIR DF 3GM 3 VAILS + DOLUTEGRAVIR (PEPFAR) 2GM 1 VAILS | India | Peru | 4 | | | |
| 2942000000 | TENOFOVIR + LAMIVUDINE + EFAVIRENZ + DOL , S-M , S-M|LOTES N¦ 22139509 FAB: 30.09.21 VENCE: 20.09.22; 20133219 FAB: 27.03.21 VENCE: 21.03.22|20136067 FAB: 29.05.21 VENCE: 16.05.22; 20116749 FAB: 12.05.21 VENCE: 06.05.22|TENOFOVIR 6GMS + LAMIVUDINE 6GMS + EFAVIRENZ 6GMS + DOLUTEGRAVIR 6GMS|WORKING STANDARD PARA CONTROL DE CALIDAD | India | Peru | 4 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (4 , 640 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122142A - MFG.DT.: 05-2022 - EXP.DT.: 04-2025 | India | Peru | 4640 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (110 , 880 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122141A , BDF122143A , BDF122144A - MFG.DT.: 05-2022 , 07-2022 - EXP.DT.: 04-2025 , 06- | India | Peru | 110880 | | | |
| 30049099 | DOLUTEGRAVIR >> DOLUTEGRAVIR 50 MG TAB30S 30049099 HSN | India | Peru | 6 | | | |
| 30049099 | TABS >> DOLUTEGRAVIR 50MG TABS 670480TABS PACK | India | Peru | 2016 | | | |
| 30042099 | DOLUTEGRAVIR 50MG/LAMIVUDINE 300MG/TENOF | India | Peru | 3326400 | | | |
| 30042099 | SAMPLES - DOLUTEGRAVIR 50MG/LAMIVUDINE 3 | India | Peru | 480 | | | |
| 30042099 | DOLUTEGRAVIR 50MG/LAMIVUDINE 300MG/TENOF | India | Peru | 1128000 | | | |
| 30049099 | LAMIVUDINE 300MG + TENOFOVIR DISOPROXILFUMARATE 300MG + DOLUTEGRAVIR SODIUM 50MG TABLETS PS:1X30S | India | Peru | 29130 | | | |
| 30049099 | LAMIVUDINE 300MG + TENOFOVIR DISOPROXILFUMARATE 300MG + DOLUTEGRAVIR SODIUM 50MG TABLETS PS:1X30S | India | Peru | 10140 | | | |
| 30049099 | DOLUTEGRAVIR 50 MG / LAMIVUDINA 300 MG /TENOFOVIR DISOPROXIL FUMARATO 300 MG TABLETS WITH SPECIAL TEXTPS:1X30S | India | Peru | 240 | | | |
| 30049099 | NET CONTENT ITEM NO 1LAMIVUDINE 13.5630KGS,TENOFOVIR DISOPROXIL FUMARATE 13.5630 KGS & DOLUTEGRAVIR SODIUM 2.2605 KGS | India | Peru | 0.00 | | | |
| 30049099 | DOLUTEGRAVIR 50MG TABS -9,691 PACKS OF 30's TABS AS PER DOCUMENT | India | Peru | 290730 | | | |
| 3004902400 | ZEVUVIR 50MG ZEVUVIR MODELO:S-M|LOTE: MTN3 MTN4 VENCE: ENERO-2025|MEDICAMENTO PARA EL TRATAMIENTO DEL VIH-SIDA (ANTIRRETROVIRAL) |PRINCIPIO ACTIVO: DOLUTEGRAVIR DE SODIO|PRESENTACION:CAJA DE 30 COMPRIMIDOS RECUBIERTOS - MUESTRA SIN VALOR COMERCIAL | Argentina | Peru | 1 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 11573 PAC | India | Peru | 347190 | | | |
| 30049099 | NET CONTENT ITEM NO 5LAMIVUDINE 90.000KGS,TENOFOVIR DISOPROXIL FUMARATE 90.000KGS & DOLUTEGRAVIR SODIUM 15.000 KGS | India | Peru | 0.00 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 1507 PAC | India | Peru | 45210 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 10000 PAC | India | Peru | 300000 | | | |
| 30049099 | SAMPLES OF NO COMMERCIAL VALUE DOLUTEGRAVIR+ LAMIVUDINE+TENOFOVIR 50MG+300 MG+300MG TABLETS 1X30S 2 PAC | India | Peru | 60 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (7040 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDJ42301A , DBJ42301B - MFG.DT.:02-2023 - EXP.DT.: 01-2026 | India | Peru | 7040 | | | |
| 30049099 | LAMIVUDINE 300MG + TENOFOVIR DISOPROXILFUMARATE 300MG + DOLUTEGRAVIR SODIUM 50MG TABLETS PS: 1X30S | India | Peru | 57600 | | | |
| 30049099 | LAMIVUDINE 300MG + TENOFOVIR DISOPROXILFUMARATE 300MG + DOLUTEGRAVIR SODIUM 50MG TABLETS PS: 1X30S | India | Peru | 153600 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (8 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDF122242C - MFG.DT.:11-2022 - EXP.DT.:10-2025 | India | Peru | 8 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (8 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDF122242B - MFG.DT.:11-2022 - EXP.DT.:10-2025 | India | Peru | 8 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (338 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDF122242C - MFG.DT.:11-2022 - EXP.DT.:10-2025 | India | Peru | 338 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (971 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDF122242B - MFG.DT.:11-2022 - EXP.DT.:10-2025 | India | Peru | 971 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (4 , 428 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122150B - MFG.DT.: 07-2022 - EXP.DT.:06-2025 | India | Peru | 4428 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (149 , 891 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122212A , BDF122219A , BDF122215A , BDF122213A - MFG.DT.:10-2022 - EXP.DT.:09-2025 | India | Peru | 149891 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (32 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122212A , BDF122219AQ , BDF122215A , BDF122213A - MFG.DT.: 10-2022 - EXP.DT.:09-2025 | India | Peru | 32 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 149891 PAC | India | Peru | 4496730 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 4428 PAC | India | Peru | 132840 | | | |
| 30049099 | SAMPLES OF NO COMMERCIAL VALUE LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS | India | Peru | 960 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (17 , 888 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122150A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 17888 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (37 , 600 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122145A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 37600 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (8 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122145A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 8 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (16 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122146A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 16 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (16 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122143A , BDF122144A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 16 | | | |
| 3004902900 | INSTGRA TABLET 1X30 , INSTGRA , S-M|BATCH H220973A EXP MAY-2024|PACK 1X30|DOLUTEGRAVIR TABLETS 50MG|MEDICAMENTOS | India | Peru | 212 | | | |
| 30042099 | SAMPLES - DOLUTEGRAVIR 50MG LAMIVUDINE 3 | India | Peru | 480 | | | |
| 30042099 | DOLUTEGRAVIR 50MG LAMIVUDINE 300MG TENOF | India | Peru | 1603560 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS - R.S: EE-08931|CAJA DE CTN CON FRASCO DE POLIETILENO DE ALTA DENSIDAD AZUL OPACO CON TAPA DE|DOLUTEGRAVIR 50MG TABLETS (30`S) - LOTE:8143766 F.V: 30-06-2025|POLIPROPILENO AZUL OPACO CONTENIENDO 30 TABLETAS RECUBIERTAS-PARA VENTA CON RECETA MEDICA | India | Peru | 1839 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS - R.S: EE-08931|CAJA DE CTN CON FRASCO DE POLIETILENO DE ALTA DENSIDAD AZUL OPACO CON TAPA DE|DOLUTEGRAVIR 50MG TABLETS (30`S) - LOTE: 8143766 F.V: 30-06-2025|POLIPROPILENO AZUL OPACO CONTENIENDO 30 TABLETAS RECUBIERTAS-PARA VENTA CON RECETA MEDICA | India | Peru | 1900 | | | |
| 30042099 | DOLUTEGRAVIR 50MG/LAMIVUDINE 300MG/TENOF | India | Peru | 139200 | | | |
| 30042099 | SAMPLES - DOLUTEGRAVIR 50MG/LAMIVUDINE 3 | India | Peru | 240 | | | |
| 30049099 | DOLUTEGRAVIR TAB 50MG 30BT | India | Peru | 1900 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 9 , 000|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG|LOTE: BDF122142C - MFG.DT.: 05-2022 - EXP.DT.: 04-2025 | India | Peru | 9000 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 191 , 334 - MFG.DT.: 05-2022 - EXP.DT.: 04-2025|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG|LOTE: BDF122133A , BDF122141A , BDF122140A , BDF122139A , BDF122137A , BDF122134A | India | Peru | 191334 | | | |
| 3004201100 | TIVICAY , GLAXOSMITHKLINE PHARMACEUTICALS S.A , S-MOD|MFG: 10-05-2021 - EXPIRA: 30-04-2026|R.D.N¦ 2485-2022-DIGEMID-DPF-EEYS-MINSA|DOLUTEGRAVIR SODIUM (TIVICAY) 50 MG TABLETS , 30 TABLETS PER BOTTLE|R.D.N¦ 455-2021-OGITT-INS - R.D.N¦ 487-2021-OGITT-INS - R.D.N¦ 050-2022-OGITT-INS | United Kingdom | Peru | 89 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 30 TABLETAS RECUBIERTAS EN FRASCO|DOLUTEGRAVIR 50MG TABLETS (30`S) - LOTE:8135449 F.V: 29-02-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - PARA VENTA CON RESETA MEDICA | India | Peru | 1704 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 30 TABLETAS RECUBIERTAS EN FRASCO|DOLUTEGRAVIR 50MG TABLETS (30`S) - LOTE:8135449 F.V: 29-02-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - PARA VENTA CON RESETA MEDICA | India | Peru | 1704 | | | |
| 30049099 | DOLUTEGRAVIR 50 MG TAB30S | India | Peru | 1704 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 30 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 1 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 30 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 1 | | | |
| 3004902400 | DOLUTEGRAVIR TABLETAS 50MG , S-M , S-M|LOTE N¦ E220039A MFG:01.2022 EXP:12.2024|DOLUTEGRAVIR 50MG TABLETA RECUBIERTA|DOLUTEGRAVIR 50MG TAB|CAJA DE CART+N , 01 FRASCO DE POLIETILENO DE ALTA DENSIDAD CON 30 TABLETAS , INCOTERMS: DPU | India | Peru | 2016 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143483 , 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 116 , 640 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 3888 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143483 , 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 296 , 150 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 43205 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143483 , 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 296 , 150 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 43205 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 458 , 000 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 48600 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 129 , 200 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 37640 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 129 , 200 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 37640 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11.2021 VENCE: 10.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 120 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 4 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11.2021 VENCE: 10.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 120 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 4 | | |
DownloadHSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
|---|
| 3004902400 | GSK1349572 50MG S/M S/M|ESTE PRODUCTO EN INVESTIGACION ES UN ANTIRETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION|POR EL VIH. ES UN FRASCO QUE CONTIENE 30 TABLETAS // LOTE: 142386775, F DE VCTO: 12/2016|DOLUTEGRAVIR (GSK1349572) X 30 COMPRIMIDOS, 50MG|GSK1349572 50MG DOLUTEGRAVIR (GSK1349572) 30 X COMPRIMIDOS | United Kingdom | Peru | 75 | | | |
| 3004902400 | GSK1349572 50MG S/M S/M|ESTE PRODUCTO EN INVESTIGACION ES UN ANTIRETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION|POR EL VIH. ES UN FRASCO QUE CONTIENE 30 TABLETAS // LOTE: 142386775, F DE VCTO: 12/2016|DOLUTEGRAVIR (GSK1349572) X 30 COMPRIMIDOS, 50MG|GSK1349572 50MG DOLUTEGRAVIR (GSK1349572) 30 X COMPRIMIDOS | United Kingdom | Peru | 103 | | | |
| 3004902400 | MEDICAMENTO TIVICAY S/M|DOLUTEGRAVIR|MEDICAMENTO DE USO HUMANO VIH/SIDA PARA ANALISIS E INVESTIGACION, PROTOCOLO AI468-048|FRASCO X 30 TABLETAS - S.V.C.|TIVICAY TAB 50MG 1BTLX30 AI 468048 OLMUL, LOTE AAC7588 VCTO 02/2017 | United Kingdom | Peru | 40 | | | |
| 3004201100 | DOLUTEGRAVIR SODICO, GLAXOSMITHKLINE, S/MOD|LOTE: 142386810 // EXPIRA: 30/06/2018 // PRINCIPIO ACTIVO: DOLUTEGRAVIR SODICO|DOLUTEGRAVIR (GSK1349572) // FRASCO CONTENIENDO 30 COMPRIMIDOS|LABELLED BOTTLE CONTAINING DOLUTEGRAVIR 30CT 50MG TABLETS|R.D.N¦ 4970-2016/DIGEMID/DPF 14/06/2016 - 14/06/2017 // PROTOCOLO: ING117175,R.D.N¦ 165-2 | United Kingdom | Peru | 165 | | | |
| 3004902400 | MEDICAMENTO TIVICAY S/M|DOLUTEGRAVIR SODICO EQUIVALENETE A 50MG DE DOLUTEGRAVIR|MEDICAMENTO DE USO HUMANO VIH/SIDA PARA ANALISIS E INVESTIGACION, PROTOCOLO AI438-047|FRASCO X 30 TABLETAS - S.V.C.|TIVICAY COMP.REC.50MG, LOTE TX4J VCTO 10/2017 | United Kingdom | Peru | 30 | | | 60 More Columns Available |
| 3004902400 | DOLUTEGRAVIR,S/M,S/M,|MEDICAMENTOS PARA TRATAMIENTO DE VIH|ES UN ANTI-RETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION POR EL VIH|FRASCO 30 TABLETAS,LOTE: 172401790 EXP.03/2019|GSK1349572 50MG DOLUTEGRAVIR 30 X COMPRIMIDOS, FRASCO QUE CONTENDRA 30 TABLETAS,N¦PARTE: G | United Kingdom | Peru | 100 | | | |
| 3004902400 | DOLUTEGRAVIR,S/M,S/M,|MEDICAMENTOS PARA TRATAMIENTO DE VIH|ES UN ANTI-RETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION POR EL VIH|FRASCO 30 TABLETAS,LOTE: 182407426 MFG:03.05.2017,EXP.31.05.2021|GSK1349572 50MG DOLUTEGRAVIR 30 X COMPRIMIDOS, FRASCO QUE CONTENDRA 30 TABLETAS,N¦PARTE: G | United Kingdom | Peru | 100 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG, GLAXO OPERATIONS UK, S/M|PRINCIPIO ACTIVO: DOLUTEGRAVIR, DTG|LOT NUMBER: 182411869 // EXPIRY DATE: 30-NOV-2020 // PROTOCOLO: GSK 205543|KIT CONTENIENDO UN FRASCO CON 30 COMPRIMIDOS DE DOLUTEGRAVIR 50MG|MUESTRAS SIN VALOR COMERCIAL | United Kingdom | Peru | 40 | | | |
| 3004902400 | GSK1349572 50MG, S/M, S/M|50 MG|PARA USO EN ESTUDIO CLINICO|DOLUTEGRAVIR 30 X COMPRIMIDOS (GSK1349572)|PK LOT: 182411495 MFG: 04/05/2017 EXPIRY 31/05/2021,NO COMMERCIAL VALUE | United Kingdom | Peru | 130 | | | |
| 3004902400 | TENOFOVIR +LAMIVUDINA+DOLUTEGRAVIR , S-M , S-M|LOTE N¦ 3132774 MFG: 04.2021 EXP: 03.2024|DOLUTEGRAVIR-LAMIVUDINA-TENOFOVIR DISOPROXIL FUMARATE 50MG-300MG-300MG|DOLUTEGRAVIR-LAMIVUDINA-TENOFOVIR DF50-300-300MG TABLETAS|73 , 000 FRASCOS X 30 COMPRIMIDOS , FABRICANTE MYLAN LABORATORIES LIMITED 3004902400 HS Code | India | Peru | 73000 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 458 , 000 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 48600 | | | |
| 3004902400 | DOLUTEGRAVIR TABLETAS 50MG , S-M , S-M|LOTE N¦ E220039A MFG:01.2022 EXP:12.2024|DOLUTEGRAVIR 50MG TABLETA RECUBIERTA|DOLUTEGRAVIR 50MG TAB|CAJA DE CART+N , 01 FRASCO DE POLIETILENO DE ALTA DENSIDAD CON 30 TABLETAS , INCOTERMS: DPU | India | Peru | 2016 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143483 , 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 116 , 640 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 3888 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 8124448 FAB: 07.2021 VENCE: 06.2024; 3142301 FAB: 10.2021 VENCE: 09.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 121 , 160 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 37372 | | | |
| 30049099 | TABLETS >> DOLUTEGRAVIR TABLETS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM FINISHED GOODS:INSTGRA TABLETS Dolutegravir Tablets 50mg PACK size 1x30 ; GOODS :INSTGRA 30049099 HS Code | India | Peru | 2648 | | | |
| 30049099 | DOLUTEGRAVIR TAB 50MG 30BT | India | Peru | 1839 | | | |
| 30042099 | DOLUTEGRAVIR 50MG LAMIVUDINE 300MG TENOF | India | Peru | 536640 | | | |
| 30049099 | DOLUTEGRAVIR 50 MG / LAMIVUDINA 300 MG /TENOFOVIR DISOPROXIL FUMARATO 300 MG TABLETS WITHOUT SPECIAL TEXTPS: 1X30S | India | Peru | 240 | | | |
| 30049099 | NET CONTENT ITEM NO 3LAMIVUDINE 104.1570 KGS,TENOFOVIR DISOPROXIL FUMARATE 104.1570KGS& DOLUTEGRAVIR SODIUM 17.3595 KGS | India | Peru | 0.00 | | | |
| 30049099 | SAMPLES OF NO COMMERCIAL VALUE DOLUTEGRAVIR+ LAMIVUDINE+TENOFOVIR 50MG+300 MG+300MG TABLETS 1X30S 2 PAC | India | Peru | 60 | | | |
| 3004201100 | DOLUTEGRAVIR SODICO, GLAXOSMITHKLINE, S/MOD|BOTTLE // LOTE: 152391726 // EXPIRA: 31/03/2019|FRASCO X 30 TABLETAS|GSK1349572 (DOLUTEGRAVIR, DTG), FILM COATED TABLETS 50 MG IN THE BOTTLE, 30 TABLETS PER|R.D.N¦ 4196-2017-DIGEMID/DPF/UFM/MINSA // R.D.N¦ 149-2017-OGITT-OPE/INS,D.S.N¦ 023-2016-S | United Kingdom | Peru | 180 | | | |
| 3004902900 | DOLUTEGRAVIR, VIIV HEALTHCARE, S/MOD|LOTE: 7ZP5316 // EXPIRA: 31/08/2019 // FRASCO CONTENIENDO 30 TABLETAS|MEMORANDUN N¦ 1949-2018-DIGEMID-DG-DFAU-UFAM/MINSA // OFICIO N¦ 1250-2018-OGCTI/MINSA|DOLUTEGRAVIR TABLET 50 MG, 30 TABLETS/BOTTLE|R.D.N¦ 5657-2018/DIGEMID/DPF/AESC/MINSA // SE ADJUNTA CARTA DE DONACION,R.D.N¦ 452-2017-OG | United States | Peru | 5 | | | |
| 3004902400 | DOLUTEGRAVIR,S/M,S/M,|MEDICAMENTOS PARA TRATAMIENTO DE VIH|ES UN ANTI-RETROVIRAL PARA EL TRATAMIENTO DE LA INFECCION POR EL VIH|FRASCO 30 TABLETAS,LOTE: 172404696 EXP.05/2021|GSK1349572 50MG DOLUTEGRAVIR 30 X COMPRIMIDOS, FRASCO CON 30 TABLETAS,N¦PARTE: GSK1349572 | United Kingdom | Peru | 100 | | | |
| 3004902400 | GSK1349572 50MG , S-M , S-M|50 MG|PARA USO EN ESTUDIO CLINICO|DOLUTEGRAVIR 30 X COMPRIMIDOS (GSK1349572) |PK LOT: 182411495 MFG: 04-05-2017 EXPIRY 31-05-2021 , NO COMMERCIAL VALUE | United Kingdom | Peru | 130 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG|PRINCIPIO ACTIVO: DOLUTEGRAVIR|LOT NUMBER: 172402704 / 172403279 // EXPIRY DATE: 31-MAY-21|KIT CONTENIENDO UN FRASCO CON 30 COMPRIMIDOS DE DOLUTEGRAVIR 50MG|MUESTRAS SIN VALOR COMERCIAL | United Kingdom | Peru | 175 | | | |
| 3004391100 | INSTGRA TABLETS|DOLUTEGRAVIR 50 MG TABLETS|S/M|MEDICAMENTO PARA EL TRATAMIENTO DEL VIH USO HUMANO|INSTGRA | India | Peru | 3464 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 8124448 FAB: 07.2021 VENCE: 06.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTTLE = 349 , 920 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 11664 | | | |
| 3004902400 | DOLUTEGRAVIR TABLETAS 50MG , S-M , S-M|LOTE N¦ 8117301 FAB: 01-2021 VENCE: 12-2022|DOLUTEGRAVIR 50MG TABLETA RECUBIERTA|DOLUTEGRAVIR 50MG TAB 30S | India | Peru | 7523 | | | |
| 3004902400 | TENOFOVIR DISOPROXIL FUMARATE 300MG + LA , S-M , S-M|LOTE N¦ 8116917 FAB: 15-01-2021 VENCE: 31-12-2023|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS.| (TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG) TAB 30`S|ANTIRRETROVIRALES PARA TRATAR PACIENTES CON VIH-SIDA | India | Peru | 73000 | | | |
| 3004902400 | TENOFOVIR +LAMIVUDINA+DOLUTEGRAVIR , S-M , S-M|LOTE N¦ 3132774 MFG: 04.2021 EXP: 03.2024|DOLUTEGRAVIR-LAMIVUDINA-TENOFOVIR DISOPROXIL FUMARATE 50MG-300MG-300MG|DOLUTEGRAVIR-LAMIVUDINA-TENOFOVIR DF50-300-300MG TABLETAS|73 , 000 FRASCOS X 30 COMPRIMIDOS , FABRICANTE MYLAN LABORATORIES LIMITED 3004902400 HS Code | India | Peru | 73000 | | | |
| 3004902400 | MEDICAMENTO ANTIVIRAL, S/M, S/M|TABLETAS DE 50/600/300MG|PARA USO Y TRATAMIENTO DE VIH / FRA C/30|PRINCIPIO ACTIVO: ABACAVIR+LAMIVUDINA+DOLUTEGRAVIR|RECETA MEDICA VISADA N¦ 452/2021 DIGEMID | Mexico | Peru | 1 | | | |
| 3004902400 | TENOFOVIR +LAMIVUDINA+DOLUTEGRAVIR, REXP, S/M|LOTE N¦ 3123261 FAB:09.2020 VENCE:08.2023|MEDICAMENTOS PARA PACIENTES CON TRATAMIENTO CR+NICOS Y PARTICULARMENTE|DOLUTEGRAVIR+LAMIVUDINA+TENOFOVIR 50/300/300MG|INFECTADOS POR VIH, FABRICANTE: MYLAN LABORATORIES LIMITED | India | Peru | 4000 | | | |
| 3004902400 | DOLUTEGRAVIR TABLETAS 50MG, S/M, S/M|LOTE N¦ 8117301 FAB: 01-2021 VENCE: 12-2022|DOLUTEGRAVIR 50MG TABLETA RECUBIERTA|DOLUTEGRAVIR 50MG TAB 30S | India | Peru | 7523 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3132179 FAB: 03.2021 VENCE: 02.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTTLE = 233 , 280 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 7776 | | | |
| 2942000000 | WORKING STANDARD TENOFOVIR + DOLUTEGRAVI , S-M , S-M|LOTE N¦ 20146751 FAB: 21.03.22 VENCE: 10.03.23; 22139509 FAB: 30.09.21 VENCE: 20.09.22|PARA USO DE CONTROL DE CALIDAD|TENOFOVIR DF 3GM 3 VAILS + DOLUTEGRAVIR (PEPFAR) 2GM 1 VAILS | India | Peru | 4 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (53 , 452 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122146A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 53452 | | | |
| 3004201100 | TIVICAY , GLAXOSMITHKLINE PHARMACEUTICALS S.A , S-MOD|MFG: 10-05-2021 - EXPIRA: 30-04-2026|R.D.N¦ 2485-2022-DIGEMID-DPF-EEYS-MINSA|DOLUTEGRAVIR SODIUM (TIVICAY) 50 MG TABLETS , 30 TABLETS PER BOTTLE|R.D.N¦ 455-2021-OGITT-INS - R.D.N¦ 487-2021-OGITT-INS - R.D.N¦ 050-2022-OGITT-INS | United Kingdom | Peru | 89 | | | |
| 2942000000 | WORKING STANDARD TENOFOVIR + DOLUTEGRAVI , S-M , S-M|LOTE N¦ 20146751 FAB: 21.03.22 VENCE: 10.03.23; 22139509 FAB: 30.09.21 VENCE: 20.09.22|PARA USO DE CONTROL DE CALIDAD|TENOFOVIR DF 3GM 3 VAILS + DOLUTEGRAVIR (PEPFAR) 2GM 1 VAILS | India | Peru | 4 | | | |
| 2942000000 | TENOFOVIR + LAMIVUDINE + EFAVIRENZ + DOL , S-M , S-M|LOTES N¦ 22139509 FAB: 30.09.21 VENCE: 20.09.22; 20133219 FAB: 27.03.21 VENCE: 21.03.22|20136067 FAB: 29.05.21 VENCE: 16.05.22; 20116749 FAB: 12.05.21 VENCE: 06.05.22|TENOFOVIR 6GMS + LAMIVUDINE 6GMS + EFAVIRENZ 6GMS + DOLUTEGRAVIR 6GMS|WORKING STANDARD PARA CONTROL DE CALIDAD | India | Peru | 4 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (4 , 640 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122142A - MFG.DT.: 05-2022 - EXP.DT.: 04-2025 | India | Peru | 4640 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (110 , 880 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122141A , BDF122143A , BDF122144A - MFG.DT.: 05-2022 , 07-2022 - EXP.DT.: 04-2025 , 06- | India | Peru | 110880 | | | |
| 30049099 | DOLUTEGRAVIR >> DOLUTEGRAVIR 50 MG TAB30S 30049099 HSN | India | Peru | 6 | | | |
| 30049099 | TABS >> DOLUTEGRAVIR 50MG TABS 670480TABS PACK | India | Peru | 2016 | | | |
| 30042099 | DOLUTEGRAVIR 50MG/LAMIVUDINE 300MG/TENOF | India | Peru | 3326400 | | | |
| 30042099 | SAMPLES - DOLUTEGRAVIR 50MG/LAMIVUDINE 3 | India | Peru | 480 | | | |
| 30042099 | DOLUTEGRAVIR 50MG/LAMIVUDINE 300MG/TENOF | India | Peru | 1128000 | | | |
| 30049099 | LAMIVUDINE 300MG + TENOFOVIR DISOPROXILFUMARATE 300MG + DOLUTEGRAVIR SODIUM 50MG TABLETS PS:1X30S | India | Peru | 29130 | | | |
| 30049099 | LAMIVUDINE 300MG + TENOFOVIR DISOPROXILFUMARATE 300MG + DOLUTEGRAVIR SODIUM 50MG TABLETS PS:1X30S | India | Peru | 10140 | | | |
| 30049099 | DOLUTEGRAVIR 50 MG / LAMIVUDINA 300 MG /TENOFOVIR DISOPROXIL FUMARATO 300 MG TABLETS WITH SPECIAL TEXTPS:1X30S | India | Peru | 240 | | | |
| 30049099 | NET CONTENT ITEM NO 1LAMIVUDINE 13.5630KGS,TENOFOVIR DISOPROXIL FUMARATE 13.5630 KGS & DOLUTEGRAVIR SODIUM 2.2605 KGS | India | Peru | 0.00 | | | |
| 30049099 | DOLUTEGRAVIR 50MG TABS -9,691 PACKS OF 30's TABS AS PER DOCUMENT | India | Peru | 290730 | | | |
| 3004902400 | ZEVUVIR 50MG ZEVUVIR MODELO:S-M|LOTE: MTN3 MTN4 VENCE: ENERO-2025|MEDICAMENTO PARA EL TRATAMIENTO DEL VIH-SIDA (ANTIRRETROVIRAL) |PRINCIPIO ACTIVO: DOLUTEGRAVIR DE SODIO|PRESENTACION:CAJA DE 30 COMPRIMIDOS RECUBIERTOS - MUESTRA SIN VALOR COMERCIAL | Argentina | Peru | 1 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 11573 PAC | India | Peru | 347190 | | | |
| 30049099 | NET CONTENT ITEM NO 5LAMIVUDINE 90.000KGS,TENOFOVIR DISOPROXIL FUMARATE 90.000KGS & DOLUTEGRAVIR SODIUM 15.000 KGS | India | Peru | 0.00 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 1507 PAC | India | Peru | 45210 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 10000 PAC | India | Peru | 300000 | | | |
| 30049099 | SAMPLES OF NO COMMERCIAL VALUE DOLUTEGRAVIR+ LAMIVUDINE+TENOFOVIR 50MG+300 MG+300MG TABLETS 1X30S 2 PAC | India | Peru | 60 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (7040 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDJ42301A , DBJ42301B - MFG.DT.:02-2023 - EXP.DT.: 01-2026 | India | Peru | 7040 | | | |
| 30049099 | LAMIVUDINE 300MG + TENOFOVIR DISOPROXILFUMARATE 300MG + DOLUTEGRAVIR SODIUM 50MG TABLETS PS: 1X30S | India | Peru | 57600 | | | |
| 30049099 | LAMIVUDINE 300MG + TENOFOVIR DISOPROXILFUMARATE 300MG + DOLUTEGRAVIR SODIUM 50MG TABLETS PS: 1X30S | India | Peru | 153600 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (8 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDF122242C - MFG.DT.:11-2022 - EXP.DT.:10-2025 | India | Peru | 8 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (8 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDF122242B - MFG.DT.:11-2022 - EXP.DT.:10-2025 | India | Peru | 8 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (338 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDF122242C - MFG.DT.:11-2022 - EXP.DT.:10-2025 | India | Peru | 338 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (971 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG+LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TR , CJ X FC 30 M|LOTE: BDF122242B - MFG.DT.:11-2022 - EXP.DT.:10-2025 | India | Peru | 971 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (4 , 428 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122150B - MFG.DT.: 07-2022 - EXP.DT.:06-2025 | India | Peru | 4428 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (149 , 891 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122212A , BDF122219A , BDF122215A , BDF122213A - MFG.DT.:10-2022 - EXP.DT.:09-2025 | India | Peru | 149891 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (32 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080 - DR 2021447889|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122212A , BDF122219AQ , BDF122215A , BDF122213A - MFG.DT.: 10-2022 - EXP.DT.:09-2025 | India | Peru | 32 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 149891 PAC | India | Peru | 4496730 | | | |
| 30049099 | LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS 1X30S 4428 PAC | India | Peru | 132840 | | | |
| 30049099 | SAMPLES OF NO COMMERCIAL VALUE LAMIVUDINE 300MG+TENOFOVIR DISOPROXIL FUMARATE 300MG+DOLUTEGRAVIR SODIUM 50MG TABLETS | India | Peru | 960 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (17 , 888 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122150A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 17888 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (37 , 600 CAJAS X 30) |MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122145A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 37600 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (8 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122145A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 8 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (16 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122146A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 16 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 30 (16 CAJAS X 30) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG TENOFOVIR DISOPROXIL FUMARATO 300MG TABLETA RECUBIERTA|LOTE: BDF122143A , BDF122144A - MFG.DT.: 07-2022 - EXP.DT.: 06-2025 | India | Peru | 16 | | | |
| 3004902900 | INSTGRA TABLET 1X30 , INSTGRA , S-M|BATCH H220973A EXP MAY-2024|PACK 1X30|DOLUTEGRAVIR TABLETS 50MG|MEDICAMENTOS | India | Peru | 212 | | | |
| 30042099 | SAMPLES - DOLUTEGRAVIR 50MG LAMIVUDINE 3 | India | Peru | 480 | | | |
| 30042099 | DOLUTEGRAVIR 50MG LAMIVUDINE 300MG TENOF | India | Peru | 1603560 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS - R.S: EE-08931|CAJA DE CTN CON FRASCO DE POLIETILENO DE ALTA DENSIDAD AZUL OPACO CON TAPA DE|DOLUTEGRAVIR 50MG TABLETS (30`S) - LOTE:8143766 F.V: 30-06-2025|POLIPROPILENO AZUL OPACO CONTENIENDO 30 TABLETAS RECUBIERTAS-PARA VENTA CON RECETA MEDICA | India | Peru | 1839 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS - R.S: EE-08931|CAJA DE CTN CON FRASCO DE POLIETILENO DE ALTA DENSIDAD AZUL OPACO CON TAPA DE|DOLUTEGRAVIR 50MG TABLETS (30`S) - LOTE: 8143766 F.V: 30-06-2025|POLIPROPILENO AZUL OPACO CONTENIENDO 30 TABLETAS RECUBIERTAS-PARA VENTA CON RECETA MEDICA | India | Peru | 1900 | | | |
| 30042099 | DOLUTEGRAVIR 50MG/LAMIVUDINE 300MG/TENOF | India | Peru | 139200 | | | |
| 30042099 | SAMPLES - DOLUTEGRAVIR 50MG/LAMIVUDINE 3 | India | Peru | 240 | | | |
| 30049099 | DOLUTEGRAVIR TAB 50MG 30BT | India | Peru | 1900 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 9 , 000|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG|LOTE: BDF122142C - MFG.DT.: 05-2022 - EXP.DT.: 04-2025 | India | Peru | 9000 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , DOLUTEGRAVIR , S-M|CAJA X 191 , 334 - MFG.DT.: 05-2022 - EXP.DT.: 04-2025|MEDICAMENTOS PARA USO HUMANO - R.D. 9196-2021 CON R.S. EE-10080|DOLUTEGRAVIR 50MG LAMIVUDINA 300MG|LOTE: BDF122133A , BDF122141A , BDF122140A , BDF122139A , BDF122137A , BDF122134A | India | Peru | 191334 | | | |
| 3004201100 | TIVICAY , GLAXOSMITHKLINE PHARMACEUTICALS S.A , S-MOD|MFG: 10-05-2021 - EXPIRA: 30-04-2026|R.D.N¦ 2485-2022-DIGEMID-DPF-EEYS-MINSA|DOLUTEGRAVIR SODIUM (TIVICAY) 50 MG TABLETS , 30 TABLETS PER BOTTLE|R.D.N¦ 455-2021-OGITT-INS - R.D.N¦ 487-2021-OGITT-INS - R.D.N¦ 050-2022-OGITT-INS | United Kingdom | Peru | 89 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 30 TABLETAS RECUBIERTAS EN FRASCO|DOLUTEGRAVIR 50MG TABLETS (30`S) - LOTE:8135449 F.V: 29-02-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - PARA VENTA CON RESETA MEDICA | India | Peru | 1704 | | | |
| 3004902400 | DOLUTEGRAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 30 TABLETAS RECUBIERTAS EN FRASCO|DOLUTEGRAVIR 50MG TABLETS (30`S) - LOTE:8135449 F.V: 29-02-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - PARA VENTA CON RESETA MEDICA | India | Peru | 1704 | | | |
| 30049099 | DOLUTEGRAVIR 50 MG TAB30S | India | Peru | 1704 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 30 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 1 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 30 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 1 | | | |
| 3004902400 | DOLUTEGRAVIR TABLETAS 50MG , S-M , S-M|LOTE N¦ E220039A MFG:01.2022 EXP:12.2024|DOLUTEGRAVIR 50MG TABLETA RECUBIERTA|DOLUTEGRAVIR 50MG TAB|CAJA DE CART+N , 01 FRASCO DE POLIETILENO DE ALTA DENSIDAD CON 30 TABLETAS , INCOTERMS: DPU | India | Peru | 2016 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143483 , 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 116 , 640 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 3888 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143483 , 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 296 , 150 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 43205 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143483 , 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 296 , 150 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 43205 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 458 , 000 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 48600 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 129 , 200 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 37640 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11-2021 VENCE: 10-2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 1 , 129 , 200 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 37640 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11.2021 VENCE: 10.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 120 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 4 | | | |
| 3004902400 | DOLUTEGRAVIR + LAMIVUDINA + TENOFOVIR , S-M , S-M|LOTE N¦ 3143502 FAB: 11.2021 VENCE: 10.2024|CAJA CON FRASCO CONTENIENDO 30 TABLETAS RECUBIERTAS|TENOFOVIR DISOPROXIL FUMARATE 300MG + LAMIVUDINE 300MG + DOLUTEGRAVIR 50MG TAB 30`S|PACKS: 30`S BOTTLE = 120 UND. - ANTIRRETROVIRALES PARA PACIENTES CON VIH-SIDA | India | Peru | 4 | | |
DownloadMarket research report
Market research report
Frequently asked questions
How to study Peru import market of Dolutegravir ?
Volza's data of Peru Dolutegravir imports allows you to study detailed data with buyer supplier names for last 10 years.
How to create strategy for Peru Dolutegravir imports ?
Volza's data of Peru Dolutegravir imports helps you create a import strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
How to find import market intelligence for Dolutegravir ?
You can find Peru Dolutegravir import market intelligence of last 10 years with buyer, supplier, price and volume from Volza.com
How to new markets for Dolutegravir imports ?
You can find New markets for Dolutegravir imports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
What is the HSN code of Dolutegravir ?
Top 5 HSN codes for Dolutegravir are HSN Code 3004902400 , HSN Code 30049099, HSN Code 3004201100, HSN Code 30042099, HSN Code 3004391100, You can check for details at https://www.volza.com/hs-codes.
How authentic is data of Peru Dolutegravir imports ?
Volza's data of Peru Dolutegravir imports is 100% authentic as it is based on actual import export shipments and is collected globally from over 20,000 ports from over 70+ Countries.
How data of Peru Dolutegravir imports can help ?
Data of Peru Dolutegravir imports contains strategic information and is very useful for importers and exporters who want to expand global trade, improve supply chain of Dolutegravir, find economical vendors, new buyers and fast growing markets.
What information does data of Peru Dolutegravir imports contains ?
Data of Peru Dolutegravir imports contains date of shipment, Name and contact details of importer, exporter, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
How frequently information on Peru Dolutegravir imports is updated ?
We update information of Peru Dolutegravir imports every month.
Where does Peru imports Dolutegravir from ?
As per the Volza's Peru import data of Dolutegravir, India accounted for maximum share with 129 shipments followed by United Kingdom with 59 and United States at 3rd spot with 59 shipments.
Where can I find latest data of Peru Dolutegravir imports ?
You can download latest data of Feb-2024 of Peru Dolutegravir imports here
Where can I find data of Peru Dolutegravir imports with names of buyers & suppliers ?
You can download Volza Peru Dolutegravir import data with names of buyers and suppliers.
What is the subscription cost of information on Peru Dolutegravir imports ?
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Whom should I contact with additional questions regarding Peru Dolutegravir imports ?
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
2 Ways to avail our services
Online |
|---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
| View More |
Volza Consulting |
|---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
| View More |
Important Links related to Dolutegravir imports
Support
Important Links
Partners
Trade Data
Follow Us:
About Us
Partners
Follow Us: